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AbstrACt
Introduction Primary healthcare (PHC) serves as 
the cornerstone for the attainment of universal health 
coverage (UHC). Efforts to promote UHC should focus 
on the expansion of access and on healthcare quality. 
However, robust quality evidence has remained scarce 
in China. Common quality assessment methods such as 
chart abstraction, patient rating and clinical vignette use 
indirect information that may not represent real practice. 
This study will send standardised patients (SP or healthy 
person trained to consistently simulate the medical history, 
physical symptoms and emotional characteristics of a real 
patient) unannounced to PHC providers to collect quality 
information and represent real practice.
Methods and analysis 1981 SP–clinician visits will be 
made to a random sample of PHC providers across seven 
provinces in China. SP cases will be developed for 10 tracer 
conditions in PHC. Each case will include a standard script 
for the SP to use and a quality checklist that the SP will 
complete after the clinical visit to indicate diagnostic and 
treatment activities performed by the clinician. Patient-
centredness will be assessed according to the Patient 
Perception of Patient-Centeredness Rating Scale by the 
SP. SP cases and the checklist will be developed through 
a standard protocol and assessed for content, face and 
criterion validity, and test–retest and inter-rater reliability 
before its full use. Various descriptive analyses will be 
performed for the survey results, such as a tabulation of 
quality scores across geographies and provider types.
Ethics and dissemination This study has been reviewed 
and approved by the Institutional Review Board of the 
School of Public Health of Sun Yat-sen University (#SYSU 
2017-011). Results will be actively disseminated through 
print and social media, and SP tools will be made available 
for other researchers.
bACkground  
In 2015, all 191 member states of the United 
Nations adopted the sustainable development 
goals, aiming to achieve universal health 
coverage (UHC)—access to high-quality 
healthcare services without incurring finan-
cial hardship—by 2030.1 As previous litera-
ture emphasised, efforts to promote UHC 
should focus on the expansion of access 
and on healthcare quality.2 Healthcare 
quality is variously defined by the WHO as 
the ‘responsiveness’ of the healthcare system 
to meet desired health outcomes,3 as the 
instrumental goals on structure, process and 
outcome in the Donabedian framework,4 and 
as the six comprehensive aims (effectiveness, 
efficiency, equity, patient-centredness, safety 
and timeliness) put forth by the Institute of 
Medicine (IOM).5 In this study, we adopt the 
IOM definition of quality.
Primary healthcare (PHC) serves as the 
cornerstone for the attainment of UHC.6 
China’s latest round of healthcare reform 
since 2009 has invested heavily in strength-
ening PHC. There have been some efforts to 
strengths and limitations of this study
 ► We will assess the quality of care with a random 
sample of primary healthcare providers in seven 
provinces in China.
 ► We will use unannounced standardised patients 
(USPs), the ‘gold standard’ of quality assessment.
 ► Both technical quality and patient-centredness will 
be assessed.
 ► USPs are not suitable for certain health conditions.
 ► The seven provinces are not randomly selected, 
although we intend for  them to represent different 
health development conditions (using life expectan-
cy as the proxy) in China’s provinces.
 o
n
 24 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023997 on 13 February 2019. Downloaded from 
2 Xu DR, et al. BMJ Open 2019;9:e023997. doi:10.1136/bmjopen-2018-023997
Open access 
assess the quality of PHC in China: patients were inter-
viewed with a Primary Care Assessment Tool questionnaire 
in Guangdong, Shanghai and Hong Kong7–9; comprehen-
siveness of the service provision was used as a proxy for 
quality through clinician interviewing10; and PHC clini-
cians’ adherence to clinical guidelines was assessed with 
a self-report questionnaire.11 However, assessment of the 
quality of PHC has largely remained scant in China, and 
the assessment tools are indirect and prone to bias.12 A 
number of studies have found the quality of PHC to be 
low in other low-income and middle-income countries 
(LMICs),6 13–18 where robust evidence remains scarce.19 
Commonly used methods of measuring technical quality 
of care include chart abstraction, patient rating of care 
and using a clinical vignette to test clinician knowledge. 
Those methods use indirect information that may not 
represent real practice. This study instead will use unan-
nounced standardised patients (USPs) to measure the 
quality of real practice. The standardised patient (SP) is 
a healthy person (or occasionally a real patient) trained 
to consistently simulate the medical history, physical 
symptoms and emotional characteristics of a real patient. 
The SP, particularly when their visit is unannounced, has 
several reported advantages: (1) reliability in measure-
ment and cross-provider comparison because the same 
patient is presented to all providers, (2) elimination of 
the Hawthorne effect (ie, that the study itself may change 
doctors’ behaviour) due to the nature of disguised and 
unannounced visit by SPs,20–22 and (3) reduced recall 
bias.23 24
Despite these advantages, the application of SP in China 
has been concentrated mainly in the area of medical 
education.25 An ongoing systematic review identified 
only four papers on using the SP for quality assessment in 
China14 26–28 and 44 in other LMICs. Those projects, often 
based on a small convenience sample, tended to target 
a limited number of conditions (approximately 70% on 
family planning services, childhood infectious diseases, 
sexually transmitted infections and respiratory tract infec-
tions). In this study, we intend to assess the quality of PHC 
with a probability sample of PHC visits in seven Chinese 
provinces, using USPs for 10 commonly seen conditions 
in the PHC setting. The project has involved 20 universi-
ties across 19 provinces in China, as well as researchers 
from Nepal, USA and UK in a USP network (https://www. 
researchgate. net/ project/ Unannounced- Standardized- 
Patient- USP- and- Virtual- Patient- VP- to- Measure- Quality- 
of- Primary- Care). The USP resources will be pooled and 
shared widely within the network first and then with the 
general public. This study is the first of a series of studies 
to be based on quality data collected using USPs. The 
primary purpose of this study is to collect and present 
descriptive data on the quality of China’s PHC. We are 
developing separate protocols for the various hypothe-
sis-driven studies, which will be available elsewhere and 
from our network website.29
MEthods
survey design
The purpose of the sample design is to create a repre-
sentative sample of China’s PHC providers so that health-
care quality can be assessed based on USP visits to those 
providers.
survey population/frame
We considered creating a nationally representative prob-
ability sample, but at this stage we have selected seven 
provinces to ‘represent’ China due to feasibility consider-
ations. These provinces represent five levels of average life 
expectancies across China’s provinces (figure 1), which 
are similar to those of five countries with low-income to 
high-income levels.30 We intend to create a probability 
sample that represents PHC in these seven provinces. For 
the survey population, we intend to include (1) licensed 
physicians and licensed assistant physicians at commu-
nity/township health centres/stations and urban health 
stations; (2) certified village doctors (a terminology in 
China that refers to village clinicians who have village-level 
practice privilege even without a medical licence) and 
village sanitarians (referring to uncertified village doctors 
who are supposed to work under the supervision of the 
village doctor) at village clinics; and (3) clinicians with a 
licence notation for general practice, internal medicine, 
obstetrics/gynaecology and paediatrics at the level I and 
level II hospitals and the maternal and childcare centres. 
We exclude level 3 hospitals, which provide more special-
ised care, and specialty hospitals. Clinicians meeting 
those criteria will constitute the ‘sampling frame’.
sampling procedures
The sample will be selected using a multistage, clus-
tered sample design covering all eligible clinicians in 
the seven provinces (figure 2). In the first stage, strati-
fication will be based on the provinces. Due to the high 
number of visits in the seven capital cities, we will sample 
each capital city. Each province is thus divided into two 
strata consisting of the provincial capital city and other 
prefecture-level municipalities, leading to 14 strata in 
total. We will use proportionate allocation (in terms of 
the number of eligible clinicians) of the sample size for 
each stratum. For each stratum, five rural townships or 
urban subdistricts (the primary sampling unit [PSU]) will 
be selected using probability proportional to size (PPS). 
In the second stage, for each PSU, PHC facilities as previ-
ously defined (secondary sampling unit [SSU]) will be 
selected using PPS systematic sampling. Neighbouring 
village clinics will be grouped as an SSU. The number of 
SSUs for each stratum will vary depending on the size of 
the stratum—for example, more SSUs will be selected in 
strata with more PHC clinicians. In the final stage, a fixed 
number of USP visits will be made to each selected facility 
or the group of facilities in the case of village clinics. The 
exact number of visits will be determined once we obtain 
and examine our sampling frame.
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sample size calculation
The sample size was calculated for the primary purpose of 
the standard descriptive survey analysis of this survey. The 
sample size (power) calculation for other related hypoth-
eses of related studies will be described in separate study 
protocols. The primary statistic of interest in this survey is 
a latent variable measuring clinicians’ quality, constructed 
using the two-parameter logistic item response theory 
(IRT) model.31 32 The model was based on a list of quality 
checklist items measuring whether doctors asked recom-
mended questions and whether they performed recom-
mended exams (see the Scoring methods section below). 
Survey sample size was calculated based on the desired 
level of relative precision (coefficient of variation, CV), an 
estimate for the population element variance for the vari-
able of interest ( s2 ) from previous study and design effect 
( deff  ). In this study, our desired level of relative precision 
(CV) is 0.08.  s2 was estimated to be 4.54, based on Sylvia et 
al’s14 27 work on the USP-assessed quality of PHC in three 
Chinese provinces. Design effect is the variance inflation 
due to cluster sampling. This figure was calculated based 
on intraclass correlation (ICC) (describing the level of 
homogeneity of the units in a cluster) and cluster sample 
size:  deff = 1 + δ
(
n− 1) , where δ is the ICC and  n is the 
average size of the cluster. The ICC of 0.0486 was also 
estimated from Sylvia et al’s work. Our estimated average 
cluster size is 27 clinician–SP encounters per PSU. 
Accordingly, we calculated the total required sample size 
to be 1981 clinician–SP encounters. The steps taken to 
calculate the sample size can be found in online supple-
mentary appendix 1.
usP case development and implementation
The development process of a USP case is based on our 
extensive literature review20 33 as well as our own USP 
experiences in Shaanxi Province, China.14 27 We are 
concurrently developing smartphone-based virtual stan-
dardised patients (VPs) (details described elsewhere). 
Figure 1 Seven selected sample provinces on the map of China with referencing countries of equivalent life expectancy in 
brackets. The figure is adapted from the paper by Liao et al29. Permission to use has been obtained.
Figure 2 Sampling procedure. PSU, primary sampling unit; SSU, secondary sampling unit; USP, unannounced 
standardised patient.
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The two projects will share almost identical case scenarios 
and quality criteria.
Case selection
Our purpose is to select 10 health problems as tracer 
conditions for PHC in China. Ideally our selected cases 
should (1) be highly prevalent in PHC settings; (2) carry 
challenging features in different aspects of PHC (eg, 
some cases focus on curative care, while others on preven-
tion, disease management, culturally sensitive care34 or 
misuse of low-value tests35–37); (3) not involve invasive and 
painful procedures; and (4) not require physical signs 
that cannot be simulated (eg, jaundice can be simulated 
with make-up, but heart murmurs cannot).23 We created 
a list of the top 30 conditions commonly seen in PHC in 
China, combining the results of two national surveys on 
PHC.12 A panel of physicians and public health and health 
system researchers then applied the principles above and 
selected a dozen of PHC problems for USP development 
(table 1). Ten final conditions will be selected from this 
list.
development team
We have created an overall development team and 10 
case-specific development teams. Each team includes 
case-specific specialists, general practitioners, and public 
health and health system researchers (online supple-
mentary appendix 2). A third overall panel consisting 
of primary care providers at the village, township and 
community levels will review all cases for contextual 
appropriateness in primary care settings. In developing 
the case, we will follow several principles: (1) limiting case 
scenarios to those that require definitive clinician action 
on the first visit to minimise potential ‘first-visit bias’,38 
(2) focusing on the presentation of symptoms for which 
evidence is well established for diagnosis and manage-
ment, and (3) deriving some content of the cases from 
the actual case history of relevant patient files in real 
practice.23
Case description
The case description describes the relevant clinical roles 
and psychosocial biographies of the SP.39 We used a struc-
tured description of the cases as follows:
1. Social and demographic profile: (1) socioeconomic 
information: name, gender, age, ethnicity, education, 
occupation, family structure (eg, married and have 
two children but live alone), dress style (eg, dressed 
in jeans, work boots and a well-worn but neat sweater), 
health insurance or other social programme partici-
pation; (2) personality that may influence interaction 
with the clinician (eg, non-proactive and introverted); 
and (3) lifestyle relevant to health (eg, smoked one 
pack of cigarette since age 18, like fried pork but also 
eat much fruit, exercise regularly, watch television a lot 
during spare time, play mah-jong with friends and visit 
children every week).
2. Medical history: (1) disease information: severity of the 
condition (eg, mild or severe depression), duration of 
the condition (the first onset? previously diagnosed/
existing [how long?]), comorbidity (any other physical 
and/or psychological problems?); (2) reason for seek-
ing care for this specific visit (eg, was feeling down for 
2 months but depression worsened last week); and (3) 
treatment/management already or currently received 
(eg, a ‘patient’ with diabetes took metoprolol for hy-
pertension but does not monitor his glucose/watch his 
diet/weight).
3. Physical examination: symptoms the SP will (and will 
not) portray (eg, reduced appetite, but not showing 
agitation), and medical signs the SP has or does not 
have (eg, heart murmur).
4. Laboratory and imaging: laboratory and imaging that 
a clinician may prescribe for the SP. The laboratory 
and imaging results of the SP may be generated from 
those of real typical patients.
5. Diagnosis: the correct diagnosis that the clinician 
should make based on the information presented by 
the SP.
6. Treatment and management: the decision of the clini-
cian on what medications, procedures, advice or refer-
ral will be given at the end of the consultation.
script
Corresponding to the six components of the aforemen-
tioned case description, we will develop a detailed script 
for the SPs to use in their PHC visit with the clinician. The 
script ideally should cover all possible questions a clini-
cian may ask, as well as the SP’s answers during the clin-
ical interaction. Panels of clinicians will be consulted to 
collect relevant questions that will guide the development 
of the script. The script will continue to add new ques-
tions asked by the clinicians on the SP–clinician interac-
tion. The script will have five sections: (1) an opening: 
spontaneous information given to the clinician at the 
start (eg, Doctor, I have had a headache for 2 days), (2) 
the information given only on request, (3) the informa-
tion for the SP to volunteer even if not asked, (4) the 
language to insist on a diagnosis if not given and (5) an 
ending.14 20 40
Quality checklist
The checklist consists of explicit quality criteria for gath-
ering data on patient history, physical examination, labo-
ratory/imaging, diagnosis and treatment.14 33 Based on 
our comprehensive review of 14 articles on literature and 
evidence-based clinical guideline development method-
ology,41 we have established a guiding principle and stan-
dard protocol for checklist development. Our process 
will (1) be evidence-based and augmented by expert 
opinion,42 (2) follow a systematic procedure to gather, 
evaluate and select evidence and criteria, (3) select 
criteria related to clinician actions that the SP can easily 
evaluate,43 and (4) keep the number of checklist items 
under 30 to include high-priority criteria only so that the 
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SP can reliably recall clinician behaviour.43–45 The details 
of our checklist development protocol will be described 
in a separate paper, and key messages are summarised in 
online supplementary appendix 2.
selecting and training sPs
We will advertise on social media to recruit SPs. The 
candidate must be in stable health without confounding 
symptoms; should match the real patients in age, sex and 
physical features; are willing to allow the examinations 
appropriate to their condition; and have the intellectual 
maturity to present the behaviour of the actual patient 
and complete the checklist.23 46 47 We may consider 
recruiting real patients with stable conditions to portray 
the cases not subject to simulation.23 The training of the 
SP will aim at portraying the signs, symptoms and presen-
tations, completing the checklist, and minimising detec-
tion by the provider.20 The week-long training will have 
three stages: classroom instruction, a dress rehearsal and 
two field tests.23 47 48 Each case will have three SPs who will 
be trained according to a standardised training manual 
that will be developed to guide the training and appraisal 
of the SPs.
Fielding and implementing sPs
A disguise plan will be developed for each case to mini-
mise physician detection of the SP status (eg, convincing 
excuse for seeking care where they do not usually reside). 
In the pilot (instrument validation) phase, consent will 
be sought for audio recording (see below); in these 
cases, fieldwork will start only 3–4 weeks after consent is 
obtained. We will provide each SP with a calamity letter, 
explaining the project in case of their identity being 
exposed.
After the facilities are selected, and the number of visits 
per facility is determined, each of the planned visits will 
be given a unique identifier (eg, facility A-1, facility A-2, 
facility B-1), which will then be randomly ordered to form 
a random sequence numbered from 1 to 1981 consecu-
tively. One of the ten SP cases will be randomly assigned 
to each number on this random sequence. The seven 
SPs per case will be dispatched to the seven provinces 
concurrently, one SP per province. If multiple clinicians 
are available in that facility at the time of a particular SP 
visit (PHC visits in China do not require appointments), 
the field coordinator will randomly select a clinician by 
drawing lots onsite. Each SP is expected to make a total 
of approximately 30 visits. We plan to complete those SP 
visits over a 3-month time span.
In a separate but related study, a week after the visit of 
the SP, the same clinician will perform the same consul-
tation but with a standardised virtual patient on a smart-
phone.29 We will use this opportunity to administer a 
detection questionnaire to the clinician, asking whether 
they suspect they had any visit from an SP over the past 
week. The detected cases will be treated as missing data 
in the data analysis.
Variables
Outcome variables
We will collect a variety of quality of care information and 
other related explanatory variables. The IOM quality 
framework (effective, safe, patient-centred, timely, effi-
cient and equitable) will be used for quality evaluation 
(table 2). Effectiveness (avoiding underuse and misuse) 
and safety (avoiding harm), traditional technical goals 
of quality of care, will be evaluated through the yes/
no checklist discussed above (online supplementary 
appendix 2). Patient-centredness (respectful of and 
responsive to individual preferences) will be assessed by 
the Patient Perception of Patient-Centeredness (PPPC) 
Rating Scale.49–51 Using a 4-point Likert scale, the PPPC 
Rating Scale evaluates three dimensions of patient-cen-
tredness: exploring the disease and illness experiences, 
understanding the whole person and finding common 
ground.49 Prior studies have demonstrated the validity 
of SPs rating clinician communications.52 53 A separate 
study will be conducted to test the validity of the PPPC 
Rating Scale. Timeliness will be assessed by analysing 
opening hours, waiting time and consultation time.5 
Efficiency (avoiding waste) will be measured by costs of 
care of the SP–clinician encounter. Equity of care (no 
variance in quality because of personal characteristics) 
will be assessed through a separate but related study in 
a randomised cross-over trial.
Scoring methods
Technical quality of care will be reflected by a contin-
uous score ranging from 0 to 1. We will evaluate further 
whether to classify checklist items in four categories 
(essential, important, indicated and non-contributory) 
with corresponding numeric weights (3, 2, 1 and 0).54 
Two scoring methods will be used: (1) the simple scoring 
method will use the formula of items performed divided 
by the total number of items on the checklist for the 
process scores, whereas (2) the complex method will use 
an algorithm based on the IRT.31 Using the IRT model 
approach, we can obtain a latent performance score for 
each doctor, which has been corrected for measurement 
error. An ordinal variable will be used for diagnosis and 
management plans (table 2), while patient-centredness 
will follow the scoring methods of the PPPC Rating Scale 
(possible range of score from 1 to 4).51
Other variables
We will collect additional information on the predictors, 
confounders and effect modifiers to the outcomes in the 
planned hypothesis testing of the related studies to this 
survey. The information will include qualifications of the 
clinician and facility information (environment, amenity, 
size, location, ownership type and so forth).
Analytical methods
USP validation
USP validation will be based on a convenience sample 
of clinicians not included in our final survey sample in 
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the project training and pilot phase. Those SP–clini-
cian interactions in the pilot will be audio-recorded and 
transcribed. Validity is the extent to which an instrument 
measures what it is supposed to measure. We will assess 
content, face and criterion validity of the cases. Content 
validity will be assessed by an expert panel who will use 
a 4-point Likert scale to evaluate the appropriateness 
of the written content of the cases that will include the 
scenario, scripts and checklists. For the checklist, they 
will be instructed to check the appropriateness against 
the published clinical guidelines. The face validity of the 
SP assessment depends on (1) the SP remaining unde-
tected (detection ratio reported to be 5%–10%55), and 
(2) authentically and consistently portraying the clinical 
features of the case. We will send the participating clini-
cian in the pilot a ‘detection form’ to report their degrees 
of suspicion of any SP visit.46 The authenticity of the SP 
presentation will be evaluated by checking the transcribed 
recording to discover whether a key piece of information 
was divulged by the SP when appropriately prompted, 
not divulged when prompted or volunteered when not 
prompted. Criterion validity will be assessed through the 
agreement of the SP-completed checklist against that 
completed by a clinician based on the transcript of the 
visit (ie, the clinician rating as the ‘gold standard’).56–59 
Checklist items which depend on visual observation will 
be excluded. Reliability examines the level of consistency 
of the repeated measurements. The inter-rater reliability 
of two SPs on the same condition and context will be 
assessed with two SPs completing the checklist for the 
same recorded transcript. Test–retest reliability will be 
analysed by the concordance of assessment results of the 
same SP to score his or her own recorded encounter a 
month later.57 The agreement will be analysed with Lin’s 
concordance correlation coefficient (rc).
60 rc indicates 
how closely pairs of observation fell on a 45° line (the 
perfect concordance line) through the origin in addition 
to their correlation.60–62 Bland-Altman plot will be used 
to visualise the concordance.63 64 Table 3 summarises our 
methods of validation.
Survey analysis
We will focus on descriptive analysis to present the quality 
of PHC in the seven provinces. Hypothesis-driven analyses 
will be described in separate study protocols. For descrip-
tive analysis, we will first present clinician and facility 
profiles in tables for all seven provinces and by each prov-
ince. The clinician profile will include sociodemographic 
information (age, gender and ethnicity), professional 
qualification (general and medical education, licen-
sure, and professional ranks) and service information 
(volume of visits and number of support personnel). The 
Table 2 Variables
Variable name Type Coding Source
1. Effectiveness and safety
  1.1 % of recommended questions asked Continuous 0–1 SP checklist
  1.2 % of recommended exams performed Continuous 0–1 SP checklist
  1.3 Diagnosis quality Ordinal 0: incorrect, 1: partially 
correct, 2: correct
SP checklist
  1.4 Treatment quality Ordinal 0: incorrect, 1: partially 
correct, 2: correct
SP checklist
2. Patient-centredness
  2.1 Patient perception of patient-centredness Continuous 0–1 PPPC
  2.2 Choice of provider Dichotomous 0: no, 1: yes SP checklist
  2.3 Ease of navigation in facility Ordinal 0: difficult, 1: median, 
2: easy
SP rating
3. Timeliness
  3.1 Opening hours Continuous Hours SP checklist
  3.2 Wait time Continuous Minutes SP checklist
  3.3 Consultation time Continuous Minutes SP checklist
4. Efficiency
  4.1 Total cost Continuous Renminbi SP checklist
  4.2 Medication cost Continuous Renminbi  SP checklist
  4.3 Laboratory/imaging cost Continuous Renminbi  SP checklist
5. Equity
  5.1 To be analysed in a separate cross-over trial
PPPC, Patient Perception of Patient-Centeredness Rating Scale; SP, standardised patient.
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facility profile will include information on operation and 
management (years in operation, ownership types, accred-
itation, level of hospitals, affiliation with medical univer-
sities, revenue, health insurance contracting, payment 
methods), clinical services (annual number of inpatient 
and outpatient visits, number of clinical departments), 
personnel (number of physicians, nurses and attrition 
ratio) and equipment. Second, we will tabulate the results 
of overall quality and subdomains across administrative 
regions and provider types. Third, we will map out the 
locations of the facilities along with their quality scores 
with geospatial analytical tools. Finally, a t-test/Wilcoxon 
test or χ2 test will be employed to compare quality differ-
ences between public versus private providers, primary 
care clinics/centres versus hospital outpatient services, 
care in rural versus urban areas, and across different 
conditions, clinician educational levels and payment 
mechanisms.
Related studies
This study protocol mainly deals with the descriptive anal-
ysis and presentation of the data to be collected by the 
Table 3 Methods of validation for the USP cases
Domain Indicator
Data collection
Statistical analysisPhase Method
Content validity Content Validity Index 
(CVI)
USP case review Expert panel review of 
SP cases, measured by 
a 4-point Likert scale 
(1=lowest, 4=highest).
CVI for SP case and 
for specific USP, where 
CVI=number of raters giving 
a rating of 3 or 4 divided by 
the total number of raters.
Face validity Authenticity of SP role-
play
Validation study Transcripts of the recording 
of the USP–clinician 
encounter to be assessed 
by a member of the 
project team for accuracy 
of portraying the clinical 
case by a 5-point Likert 
scale (1=100% inaccurate, 
5=100% accurate).
Accuracy score=per cent of 
positive evaluations (ie, 
evaluation ≥4).
Detection ratio Clinicians receiving an 
SP visit to complete 
a ‘detection form’ 
afterwards to report 
any suspected USP 
visits: 0=not suspected; 
1=somehow suspected; 
2=suspected with certainty).
Detection ratio=number of 
detected USP visit divided 
by the total number of USP 
visits (for case-specific 
detection ratio and all-
case detection ratio, 
respectively). Detection 
ratio of 10% and less 
is considered acceptable.
Criterion validity Lin’s concordance 
correlation coefficient 
(rc); kappa statistic
Validation study SP-completed checklist 
against that by a clinician 
based on the transcript of 
the visit (ie, the clinician 
rating as the ‘reference 
standard’).
The concordance of the 
quality scores based on 
SP-completed checklist 
against that based on the 
reference standard. rc used 
for continuous process 
quality scores, and kappa 
for dichotomous diagnoses 
and treatment and 
management measures.
Test–retest reliability Lin’s concordance 
correlation coefficient 
(rc); kappa statistic
Validation study. The same SP to score his 
own recorded encounter in 
a month.
The concordance to 
be examined by rc for 
continuous process quality 
scores, fees charged (yuan) 
and time spent (min), and 
kappa for dichotomous 
diagnoses and treatment 
and management 
measures.
Inter-rater reliability Multiple SPs to complete 
the checklist for the same 
recorded transcript.
SP, standardised patient; USP, unannounced standardised patient. 
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USPs. Using the USP survey data, we have planned several 
related studies that will be covered by separate study proto-
cols with details on the background, theoretical framework 
and analytical methods. To summarise those related studies, 
we will assess (1) the effect of ownership types of the PHC 
providers (ie, private vs public) on the quality of PHC (study 
protocol under revision), (2) the know-do gap between 
the assessment results by a smartphone-based VPs and 
USP (protocol already published),29 (3) the effect of using 
smartphone-based virtual patient in improving clinician 
performance, (4) the effect of types of insurance carried by 
a patient on quality of care, (5) the impact of gatekeeping 
by primary care providers on quality of tuberculosis care—a 
mathematical modelling study, and (6) clinician skills in 
handling low-value or harmful patient-requested services, 
particularly antibiotics and some processed traditional 
Chinese medicine.
Ethics and dissemination
USP studies do not necessarily require consent if they meet 
certain conditions.65 66 Our waiver has been granted for the 
following reasons: (1) our study serves important public 
good, while requiring informed consent may lead to consid-
erable selection bias and greater risk for the detection of 
the SP; (2) this study does not intend to entrap or reveal 
identities of any institution or individual, and all analyses 
will be conducted at the broader health system level (after 
data cleaning, all individual identifiers will be destroyed); 
and (3) no audiovisuals will be recorded during the SP–
clinician encounter (however, in the pilot stage, we will seek 
informed consent from participating clinicians as we will 
use a disguised recording for the validation purposes). The 
study results will be widely distributed in the form of scien-
tific papers and policy briefs. The data generated from this 
project and the USP cases and accompanying user manuals 
will be made available to other researchers on request after 
we complete our primary analysis.
Patient and public involvement
We selected the conditions for the USP partly based on 
results from surveys on common conditions in the context 
of PHC as reported by patients. The USP cases will also be 
reviewed by a panel that includes patients. The results of 
the studies will be widely distributed in scientific reports as 
well as social media to benefit policymakers, clinicians and 
patients.
dIsCussIon
In this study, we will develop, validate and implement 
methods of assessing the quality of PHC using USPs. 
Compared with existing studies using USPs,33 this 
proposed study has several distinctive features. First, 
we will establish a large probability random sample 
so that representative estimates of PHC quality can 
be achieved in the chosen seven provinces in China. 
Second, unlike previous studies,14 27 we include village 
clinics, township health centres and community health 
centres, and also county hospitals and other level I and 
level II hospitals, in the study. The latter were not offi-
cially designated as PHC facilities in China but provided 
a substantial amount of PHCs. Third, 10 SP cases will 
be developed through a standardised process using the 
same template and methodology and will represent 
common conditions in PHC, while past studies often 
used two to three conditions.33 Fourth, an evidence-
based systematic method will guide checklist develop-
ment. In a review, only 12 out of 29 SP articles reported 
the procedures of checklist development and many 
checklists were developed by expert consensus only.54 
Fifth, in addition to using the checklist to evaluate tech-
nical quality of care as performed in most other USP 
studies, we will assess patient-centredness with a global 
rating scale. Sixth, we have planned a series of related 
studies to address the quality of PHC in a concerted 
effort. Most noteworthy, we are developing 10 iden-
tical conditions as smartphone-based virtual patients 
to assess the competency of PHC providers. Seventh, 
we used the same case for all levels of providers, from 
village doctors to township health centres, to county 
hospitals, but quality checklists for process, diagnosis 
and treatment will be tailored to fit the expected roles 
and responsibilities of the different providers. Finally, 
we have secured the understanding and cooperation of 
the provincial health authorities.
We note two particular issues. In high-income settings, 
logistical arrangements for the SP are complex. A signif-
icant challenge is to introduce the SP into medical prac-
tice.23 47 48 However, in China and many other LMICs, 
enrolment with a clinician is not required, and a walk-in 
visit to clinicians without an appointment is common-
place. However, village doctors usually know their patients 
well. For these areas, the SPs in other studies pretended 
to be tourists or friends visiting the families in the village. 
We will try other pretences, such as a temporary pover-
ty-relief worker who has just arrived in a nearby village. 
Those poverty-relief workers are common in remote rural 
areas in China. For the second issue, assessing quality 
with USP was reported to incur high cost in developed 
countries (estimated to be US$350–400 per visit).53 67 We 
expect the cost in China to be considerably lower due to 
the lower labour cost. We will collect detailed cost infor-
mation to inform the future application of the USP.
The study has several potential limitations. Most 
important, even though the assessment of SP is consid-
ered the gold standard for measuring clinician perfor-
mance, and in this study we have further expanded the 
use of SPs to evaluate other elements of quality in the 
IOM framework such as patient-centredness, timeliness 
and efficiency, we recognise that those quality of care 
elements are still largely clinician-related, and other 
important quality aspects such as the quality of laboratory 
testing cannot be assessed by our SPs. In addition, the 
USP method has several technical challenges. If healthy 
people are used to simulate the patient, it is difficult to 
achieve complete alignment of patient presentation of 
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signs and symptoms (for instance, it is difficult to fake 
a sore throat). There are also challenges to obtaining 
fake laboratory test results that may be necessary for the 
diagnosis. Some clinical roles that require the SP to go 
through invasive investigation may also pose a problem. 
We will experiment with a real patient in stable conditions 
to resolve some of those challenges. Next, our judgement 
of the clinical quality through the first and only visit with 
the SP may lead to ‘first-visit bias’.38 The quality of care 
provided by a clinician who spreads his or her diagnosis 
and management over several visits may be underesti-
mated. We try to minimise this bias by designing cases 
that require a definitive decision on the first visit. Last, 
even though we intend to select 10 tracer conditions in 
the context of PHC, we still need to be cautious in gener-
alising the findings to the overall quality of PHC.
In conclusion, this proposed study may produce a set 
of validated tools for the assessment of the quality of PHC 
using USP and apply it to obtain valuable quality of care 
information on PHC in China.
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